Listen in!
In recognition of World Heart Day, an expert panel of cardiologists shared the latest data and strategies for improving the diagnosis and management of coronary artery disease (CAD) and data-based benefits of a CCTA-first pathway.
Learning Objectives:
- Increasing global awareness for advances in cardiovascular disease diagnosis, specifically CAD
- Sharing the latest data on why to choose a CCTA-first pathway for patients with stable chest pain
- Discussing strategies to safely defer testing in low-risk patients
- Exploring patient benefits of the CCTA+FFRCT diagnostic pathway
- Understanding how the CCTA pathway enables clinicians to take more informed and expedited patient care decisions
- Defining methods to improve cath lab efficiency and reduce unnecessary CV tests
Who should attend:
- Cardiologists
- Interventional Cardiologists
- General Practitioners
- NPs
- PAs
- CV Nurses
- Cardiovascular Imaging Specialists
- Cardiovascular Service Line Directors
- Cath Lab Directors
- CT Technologists
Panel:
Chief of Cardiology, Tufts Medical Center and Professor of Medicine and Radiology, Tufts University School of Medicine Boston, Massachusetts, USA
|
Assistant Professor of Medicine, Department of Medicine, Division of Cardiology, Duke University, Durham, North Carolina, USA
|
TIMOTHY FAIRBAIRN, |
What is World Heart Day?
For more than two decades, the World Heart Federation has been leading the World Heart Day movement— informing people around the world that cardiovascular disease (CVD), including heart disease and stroke, is the leading cause of death globally. More than 20 million lives are lost every year because of CVD, and World Heart Day on September 29th is an opportunity to highlight the actions that healthcare professionals can take to prevent and manage CVD.